Literature DB >> 8190533

Nosocomial Malassezia pachydermatis bloodstream infections in a neonatal intensive care unit.

S F Welbel1, M M McNeil, A Pramanik, R Silberman, A D Oberle, G Midgley, S Crow, W R Jarvis.   

Abstract

Malassezia pachydermatis, a lipophilic yeast, has been described to cause sporadic nosocomial bloodstream infections (BSI). Nosocomial outbreaks of M. pachydermatis BSI have never been described. A cluster of M. pachydermatis BSIs in the neonatal intensive care unit at Louisiana State University Medical Center, University Hospital provided the opportunity to investigate the epidemiology of this organism and apply molecular epidemiologic typing techniques. A case-patient was defined as any neonatal intensive care unit patient in University Hospital with a blood culture positive for M. pachydermatis from January 1, 1989, through August 15, 1991. Five patients met the case definition. Case-patients were premature as estimated by gestational age and required prolonged hospitalization. Case-patients received parenteral nutrition and intravenous lipids for twice as many days as randomly selected controls. No environmental source of M. pachydermatis was identified; however, infants on each side of a previously identified M. pachydermatis-colonized infant became colonized with M. pachydermatis during a 20-day period. Chromosomal analysis of five M. pachydermatis blood isolates from two case-patients had identical banding patterns. These data show that M. pachydermatis can cause nosocomial BSI outbreaks, that premature infants receiving parenteral nutrition and/or lipids may be at greatest risk and that transmission is most likely from person to person, probably via the hands of medical personnel.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8190533     DOI: 10.1097/00006454-199402000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  15 in total

1.  Extracellular enzymatic activity of Malassezia spp. isolates.

Authors:  F Mancianti; A Rum; S Nardoni; M Corazza
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

2.  Otitis externa associated with Malassezia sympodialis in two cats.

Authors:  M J Crespo; M L Abarca; F J Cabañes
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

Review 3.  Hospital-related outbreaks due to rare fungal pathogens: a review of the literature from 1990 to June 2011.

Authors:  E C Repetto; C G Giacomazzi; F Castelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-03       Impact factor: 3.267

4.  Atypical lipid-dependent Malassezia species isolated from dogs with otitis externa.

Authors:  M J Crespo; M L Abarca; F J Cabañes
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

5.  Occurrence and population size of Malassezia spp. in the external ear canal of dogs and cats both healthy and with otitis.

Authors:  Claudia Cafarchia; Sabrina Gallo; Gioia Capelli; Domenico Otranto
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

6.  Epidemiology of nosocomial fungal infections.

Authors:  S K Fridkin; W R Jarvis
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 7.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

8.  Skin Colonization by Malassezia spp. in hospitalized neonates and infants in a tertiary care centre in North India.

Authors:  Prerna Gupta; Arunaloke Chakrabarti; Sunit Singhi; Praveen Kumar; Prasanna Honnavar; Shivaprakash M Rudramurthy
Journal:  Mycopathologia       Date:  2014-07-19       Impact factor: 2.574

9.  In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.

Authors:  Margarita Garau; Manolo Pereiro; Amalia del Palacio
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

10.  Malassezia pachydermatis carriage in dog owners.

Authors:  Daniel O Morris
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.